Ascendis Pharma A/SASNDNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+11.5%
5Y CAGR+1.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+11.5%/yr
vs +12.5%/yr prior
5Y CAGR
+1.0%/yr
Recent acceleration
Acceleration
-1.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $615.78M | +10.1% |
| 2024 | $559.54M | +42.7% |
| 2023 | $392.16M | -11.8% |
| 2022 | $444.77M | -0.3% |
| 2021 | $446.27M | -23.7% |
| 2020 | $584.52M | -2.3% |
| 2019 | $598.11M | +115.3% |
| 2018 | $277.86M | +42.2% |
| 2017 | $195.35M | +8.3% |
| 2016 | $180.33M | - |